Litcius/Paper detail

Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption

Phoebe Mondala, Ashni A. Vora, Tianyuan Zhou, Elisa Lazzari, Luisa Ladel, Xiaolin Luo, Youngsoo Kim, Caitlin Costello, A. Robert MacLeod, Catriona Jamieson, Leslie Crews

2021Cell stem cell63 citationsDOIOpen Access PDF

Topics & Concepts

IRF4Cancer researchMultiple myelomaProgenitor cellBiologyStem cellHaematopoiesisImmunologyCell biologyTranscription factorGeneticsGeneMultiple Myeloma Research and TreatmentsUbiquitin and proteasome pathwaysProtein Degradation and Inhibitors
Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption | Litcius